Nexien BioPharma Inc (NXEN)
0.0204
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Nexien BioPharma Total Liabilities (Quarterly): 0.3396M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.3396M |
| December 31, 2023 | 0.3168M |
| September 30, 2023 | 0.3129M |
| June 30, 2023 | 0.2951M |
| March 31, 2023 | 0.2885M |
| December 31, 2022 | 0.2793M |
| September 30, 2022 | 0.2656M |
| June 30, 2022 | 0.2421M |
| March 31, 2022 | 0.2073M |
| December 31, 2021 | 0.0654M |
| September 30, 2021 | 0.0474M |
| June 30, 2021 | 0.0393M |
| March 31, 2021 | 0.0127M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.0304M |
| September 30, 2020 | 0.0247M |
| June 30, 2020 | 0.0292M |
| March 31, 2020 | 0.0223M |
| December 31, 2019 | 0.0185M |
| September 30, 2019 | 0.0222M |
| June 30, 2019 | 0.0447M |
| March 31, 2019 | 0.0078M |
| December 31, 2018 | 0.0116M |
| September 30, 2018 | 0.0515M |
| June 30, 2018 | 0.0888M |
| March 31, 2018 | 0.0531M |
| December 31, 2017 | 0.0567M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0127M
Minimum
Mar 2021
0.3396M
Maximum
Mar 2024
0.1452M
Average
0.0564M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0143M |
| Shareholders Equity (Quarterly) | -0.3253M |